In contrast, our previous study [38] showed that 5-FU significantly increased the mRNA expression of all investigated ABC transporters, as well as P-gp protein levels, in these colon cancer cells, underscoring a distinct regulatory profile for isorhamnetin with potential therapeutic advantages. The gene discussed is ABCG2; the disease is colonic neoplasm.